Clinical Trial Update: HS-IT101 Injection for Advanced NSCLC [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for HS-IT101 Injection in advanced non-small cell lung cancer, with the study listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• HS-IT101 Injection (HS-IT101)

Snippet

Sponsor: Qingdao Sino-Cell Biomedicine Co., Ltd. | Conditions: Advanced Non-Small Cell Lung Cancer | Phase 1 | Status: NOT_YET_RECRUITING